Brian T. Hill
Cleveland Clinic(US)Cancer Institute (WIA)(IN)Cleveland Clinic Lerner College of Medicine(US)Fred Hutch Cancer Center(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Acute Lymphoblastic Leukemia research, Hematopoietic Stem Cell Transplantation
Most-Cited Works
- → Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma(2017)5,739 cited
- → Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial(2018)2,184 cited
- → KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma(2020)1,759 cited
- → Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium(2020)762 cited
- → Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis(2018)444 cited
- → MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies(2015)371 cited